12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
週五盤後交易時段，12只醫療保健類股走勢
Gainers
獲勝者
- Singular Genomics Sys (NASDAQ:OMIC) shares moved upwards by 17.9% to $0.66 during Friday's after-market session. The market value of their outstanding shares is at $48.4 million.
- Vaccinex (NASDAQ:VCNX) stock increased by 11.61% to $0.77. The company's market cap stands at $9.6 million.
- Celularity (NASDAQ:CELU) shares moved upwards by 7.52% to $0.46. The market value of their outstanding shares is at $99.5 million.
- ZyVersa Therapeutics (NASDAQ:ZVSA) stock rose 6.87% to $0.62. The company's market cap stands at $1.0 million.
- BioXcel Therapeutics (NASDAQ:BTAI) stock moved upwards by 5.21% to $2.22. The company's market cap stands at $66.4 million.
- Turnstone Biologics (NASDAQ:TSBX) shares rose 4.62% to $2.26. The market value of their outstanding shares is at $52.1 million.
- 在週五的盤後交易中，Singular Genomics Sys（納斯達克股票代碼：OMIC）股價上漲了17.9％，至0.66美元。他們已發行股票的市值爲4,840萬美元。
- Vaccinex（納斯達克股票代碼：VCNX）股價上漲11.61％，至0.77美元。該公司的市值爲960萬美元。
- Celularity（納斯達克股票代碼：CELU）股價上漲7.52％，至0.46美元。他們已發行股票的市值爲9,950萬美元。
- ZyVersa Therapeutics（納斯達克股票代碼：ZVSA）股價上漲6.87％，至0.62美元。該公司的市值爲100萬美元。
- BioXcel Therapeutics（納斯達克股票代碼：BTAI）股價上漲5.21％，至2.22美元。該公司的市值爲6,640萬美元。
- Turnstone Biologics（納斯達克股票代碼：TSBX）股價上漲4.62％，至2.26美元。他們已發行股票的市值爲5,210萬美元。
Losers
失敗者
- Intelligent Bio Solutions (NASDAQ:INBS) stock declined by 15.8% to $5.7 during Friday's after-market session. The market value of their outstanding shares is at $4.1 million.
- Perspective Therapeutics (AMEX:CATX) stock fell 8.9% to $0.82. The company's market cap stands at $405.5 million.
- NanoString Technologies (NASDAQ:NSTG) stock decreased by 7.83% to $0.21. The market value of their outstanding shares is at $10.2 million.
- Bone Biologics (NASDAQ:BBLG) shares declined by 6.36% to $3.83. The company's market cap stands at $2.0 million.
- Actinium Pharma (AMEX:ATNM) stock decreased by 4.95% to $5.19. The market value of their outstanding shares is at $144.0 million.
- Biolase (NASDAQ:BIOL) stock declined by 4.94% to $0.48. The company's market cap stands at $1.6 million. See Also:
- 智能生物解決方案（納斯達克股票代碼：INBS）股價在週五的盤後交易中下跌了15.8％，至5.7美元。他們已發行股票的市值爲410萬美元。
- 透視療法（美國證券交易所股票代碼：CATX）股價下跌8.9％，至0.82美元。該公司的市值爲4.055億美元。
- NanoString Technologies（納斯達克股票代碼：NSTG）股價下跌7.83％，至0.21美元。他們已發行股票的市值爲1,020萬美元。
- Bone Biologics（納斯達克股票代碼：BBLG）股價下跌6.36％，至3.83美元。該公司的市值爲200萬美元。
- Actinium Pharma（美國證券交易所股票代碼：ATNM）股價下跌4.95％，至5.19美元。他們已發行股票的市值爲1.44億美元。
- Biolase（納斯達克股票代碼：BIOL）股價下跌4.94％，至0.48美元。該公司的市值爲160萬美元。另見：
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。